![Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages](https://www.frontiersin.org/files/Articles/369164/fmicb-09-00915-HTML/image_m/fmicb-09-00915-t002.jpg)
Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebul
![Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00134-007-0935-1/MediaObjects/134_2007_935_Fig2_HTML.gif)
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
![Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-86342-8/MediaObjects/41598_2021_86342_Fig1_HTML.png)
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
![Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine](https://medicineinnovates.com/wp-content/uploads/2022/03/external-figure.jpg)
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine
![In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fcc12019/MediaObjects/13054_2013_Article_1176_Fig2_HTML.jpg)
In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text
![PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE](https://www.researchgate.net/profile/Nani-Kadrichu/publication/278297310/figure/tbl1/AS:614002572947463@1523401029825/n-vitro-study-parameters-on-vent-and-handheld-configurations_Q320.jpg)